Stocks and InvestingStocks and Investing
Mon, September 26, 2022
Fri, September 23, 2022
Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022

Robert Burns Maintained (ADCT) at Strong Buy with Increased Target to $21 on, Sep 19th, 2022


Published on 2024-10-27 23:02:59 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Increased Target from $20 to $21 on, Sep 19th, 2022.

Robert has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $11 on, Friday, September 9th, 2022


This is the rating of the analyst that currently disagrees with Robert


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $29 on, Wednesday, August 10th, 2022